Experience with Elizabethkingia meningoseptica Infection in Adult Patients at a Tertiary Hospital
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Few reports have documented the clinical characteristics and treatment outcomes of adult patients with Elizabethkingia meningoseptica infection. Methods: Medical records of patients over 18 years of age and suspected of having an E. meningoseptica infection from March 1, 2006 to February 28, 2013 were reviewed retrospectively. Their clinical characteristics, antimicrobial susceptibility results, and treatment outcomes were analyzed. Results: E. meningoseptica was isolated from 30 patients. Median age was 68.5 years, and infections were more frequent in males (17, 56.7%). The most common isolation source was sputum (23, 76.7%), and pneumonia was the most common condition (21, 70%) after excluding two cases of colonization. This bacterium was most susceptible to minocycline (27, 90%) and fluoroquinolones, including levofloxacin (20, 66.7%) and ciprofloxacin (18, 60%). The mortality rate due directly to E. meningoseptica infection was 20% (6/30), and uncontrolled pneumonia was the only cause of death. After isolating E. meningoseptica, the numbers of patients with pneumonia (9/9, 100% vs. 12/21, 57.1%), history of hemodialysis (5/9, 55.6% vs. 3/21, 14.3%), tracheostomy (8/9, 88.9 vs. 10/21, 47.6%), and median Charlson comorbidity index score (6 [range, 3–9] vs. 4 [range, 0–9]) were significantly higher in non-survivors than those in survivors (p < 0.05, for each). However, only 12 (40%) patients received appropriate antibiotics. Conclusions: E. meningoseptica infection most commonly presented as pneumonia in adults with severe underlying diseases. Despite the high mortality rate, the rate of appropriate antibiotic use was notably low.
Abstract
Background: Few reports have documented the clinical characteristics and treatment outcomes of adult patients with Elizabethkingia meningoseptica infection. Methods: Medical records of patients over 18 years of age and suspected of having an E. meningoseptica infection from March 1, 2006 to February 28, 2013 were reviewed retrospectively. Their clinical characteristics, antimicrobial susceptibility results, and treatment outcomes were analyzed. Results: E. meningoseptica was isolated from 30 patients. Median age was 68.5 years, and infections were more frequent in males (17, 56.7%). The most common isolation source was sputum (23, 76.7%), and pneumonia was the most common condition (21, 70%) after excluding two cases of colonization. This bacterium was most susceptible to minocycline (27, 90%) and fluoroquinolones, including levofloxacin (20, 66.7%) and ciprofloxacin (18, 60%). The mortality rate due directly to E. meningoseptica infection was 20% (6/30), and uncontrolled pneumonia was the only cause of death. After isolating E. meningoseptica, the numbers of patients with pneumonia (9/9, 100% vs. 12/21, 57.1%), history of hemodialysis (5/9, 55.6% vs. 3/21, 14.3%), tracheostomy (8/9, 88.9 vs. 10/21, 47.6%), and median Charlson comorbidity index score (6 [range, 3–9] vs. 4 [range, 0–9]) were significantly higher in non-survivors than those in survivors (p < 0.05, for each). However, only 12 (40%) patients received appropriate antibiotics. Conclusions: E. meningoseptica infection most commonly presented as pneumonia in adults with severe underlying diseases. Despite the high mortality rate, the rate of appropriate antibiotic use was notably low.
참고문헌 (30)
- Bloch KC, "Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults. Report of 6 cases and literature review", Medicine (Baltimore), 76, pp.30~41 (1997)
- Weaver KN, "Acute emergence of Elizabethkingia meningoseptica infection among mechanically ventilated patients in a long-term acute care facility", Infect Control Hosp Epidemiol, 31, pp.54~58 (2010)
- Kirby JT, "Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001)", J Clin Microbiol, 42, pp.445~448 (2004)
- Ceyhan M, "A Chryseobacterium meningosepticum outbreak observed in 3 clusters involving both neonatal and non-neonatal pediatric patients", Am J Infect Control, 36, pp.453~457 (2008)
- Güngör S, "A Chryseobacterium meningosepticum outbreak in a neonatal ward", Infect Control Hosp Epidemiol, 24, pp.613~617 (2003)
- Chiu CH, "Atypical Chryseobacterium meningosepticum and meningitis and sepsis in newborns and the immunocompromised, Taiwan", Emerg Infect Dis, 6, pp.481~486 (2000)
- Hsu MS, "Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006", Eur J Clin Microbiol Infect Dis, 30, pp.1271~1278 (2011)
- Hung PP, "Chryseobacterium meningosepticum infection: antibiotic susceptibility and risk factors for mortality", J Microbiol Immunol Infect, 41, pp.137~144 (2008)
- Pokrywka M, "A Flavobacterium meningosepticum outbreak among intensive care patients", Am J Infect Control, 21, pp.139~145 (1993)
- Fujita J, "Respiratory infection caused by Flavobacterium meningosepticum", Lancet, 335, pp.544~ (1990)
- Brown RB, "Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymyxin B", Am J Infect Control, 17, pp.121~125 (1989)
- Jean SS, "Elizabethkingia meningoseptica: an important emerging pathogen causing healthcare-associated infections", J Hosp Infect, 86, pp.244~249 (2014)
- Pereira GH, "Nosocomial infections caused by Elizabethkingia meningoseptica: an emergent pathogen", Braz J Infect Dis, 17, pp.606~609 (2013)
- 구향모, "복막투석 환자에서 발생한 Chryseobacterium meningosepticum 복막염 1예", Kidney Research and Clinical Practice, 30(3), pp.339~342 (2011), 대한신장학회
- 김성준, "Chryseobacterium meningosepticum에 의한 지역사회 획득 폐렴 및 패혈증 1예", 대한내과학회지, 79(4), pp.453~456 (2010), 대한내과학회
- 윤혜선, "Two cases of Chryseobacterium meningosepticum infectionin a neonatal intensive care unit", Korean Journal of Pediatrics, 50(7), pp.698~701 (2007), 대한소아과학회
- 이영숙, "지속성 외래 복막투석 (CAPD) 환자에서 발생한Chryseobacterium (Flavobacterium)meningosepticum과 녹농균의 복합 균주 복막염 1예", Kidney Research and Clinical Practice, 21(5), pp.15~819 (2002), 대한신장학회
- Choi HY, "Ventriculitis by nosocomial Flavobacterium meningosepticum in neonates:neurosonographic findings", J Korean Soc Med Ultrasound, 11, pp.95~100 (1992)
- 양영성, "Keratitis with Elizabethkingia meningoseptica Occurring afterContact Lens Wear: A Case Report", Korean Journal of Ophthalmology, 27(2), pp.133~136 (2013), 대한안과학회
- 김자영, "국내 일개 병원에서의 Elizabethkingia meningoseptica 성인 감염 3예", Annals of Clinical Microbiology, 14(4), pp.153~157 (2011), 대한임상미생물학회
- Jong Hwa Yum, "Genetic Diversity of Chromosomal Metallo-β-Lactamase Genes in Clinical Isolates of Elizabethkingia meningoseptica from Korea", The Journal of Microbiology, 48(3), pp.358~364 (2010), 한국미생물학회
- Bellais S, "Genetic diversity of carbapenem-hydrolyzing metallobeta-lactamases from Chryseobacterium (Flavobacterium)indologenes", Antimicrob Agents Chemother, 44, pp.3028~3034 (2000)
- González LJ, "Carbapenem resistance in Elizabethkingia meningoseptica is mediated by metallo-β-lactamase BlaB", Antimicrob Agents Chemother, 56, pp.1686~1692 (2012)
- Lee NY, "Annual report on external quality assessment in clinical microbiology laboratory in Korea (2008)", J Lab Med Qual Assur, 31, pp.13~27 (2009)
- Lin YT, "Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan", Scand J Infect Dis, 41, pp.628~634 (2009)
- Fraser SL, "Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing", Antimicrob Agents Chemother, 41, pp.2738~2741 (1997)
- Amer MZ, "Neonatal meningitis caused by Elizabethkingia meningoseptica in Saudi Arabia", J Infect Dev Ctries, 5, pp.745~747 (2011)
- Lee SW, "Chryseobacterium meningosepticum sepsis complicated with retroperitoneal hematoma and pleural effusion in a diabetic patient", J Chin Med Assoc, 71, pp.473~476 (2008)
- Tizer KB, "Successful combination vancomycin and rifampin therapy in a newborn with community-acquired Flavobacterium meningosepticum neonatal meningitis", Pediatr Infect Dis J, 14, pp.916~917 (1995)
- Tekerekoglu MS, "Analysis of an outbreak due to Chryseobacterium meningosepticum in a neonatal intensive care unit", New Microbiol, 26, pp.57~63 (2003)